Atlas Trials

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Clinical trial NCT06463717 · RECRUITING

Trial details

NCT number
NCT06463717
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple MyelomaMinimal Residual Disease
Start date
2023-12-01
Primary completion
2028-11-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.